Remarkably, theobromine could prevent angiogenesis in lung cancer in an in vivo study [21] as well as it exhibits promising anti-angiogenic activity via the inhibition of the vascular endothelial growth factor (VEGF), in vivo and in vitro, in ovarian cancer [22]. This evidence concerns the gene VEGFA and ovarian cancer.